Advanced Search

 

Study ID Status Title Patient Level Data
115064 Relinquished Determination of the Absolute Bioavailability of GSK1120212 Following a Single Oral Dose Co-Administered with an Intravenous Radiolabelled Microdose of GSK1120212 in Subjects with solid Tumors
115066 Completed Drug Use Investigation for XYZAL
115067 Completed A Meta Analysis to compare the efficacy of Acyclovir 3% ophthalmic ointment to Idoxuridine in curing herpes keratitis after 7-days of treatment
115068 Active, Not Recruiting Special Drug Use Investigation for XYZAL (Long-term)
115070 Completed Phase1 study of GR121167- A double blind, placebo controlled, randomized, dose ascending, single and multiple dose study to investigate the safety and pharmacokinetics following intravenous administration of GR121167 in healthy Japanese males- Study Listed on ClinicalStudyDataRequest.com
115077 Completed Genetic analysis of a phase IV study of inhaled zanamivir in pediatrics
115083 Completed A Phase I Study to Evaluate a Single Oral Dose of SRT2379 on the Endotoxin Induced Inflammatory Response in Healthy Male Subjects Study Listed on ClinicalStudyDataRequest.com
115096 Completed A Randomized, Open-label, Single-Dose, Two-Period, Crossover Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
115102 Completed A double-blind, randomized, placebo controlled, multicenter, dose-finding trial of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) patients
115114 Completed Validation of the new COPD Assessment Test translated into Korean in patients with Chronic Obstructive Pulmonary Disease
115115 Completed Safety and immunogenicity study of a prime-boost schedule of GSK Biologicals' influenza vaccine GSK1562902A in children aged 3 to 17 years Study Listed on ClinicalStudyDataRequest.com
115117 Completed A single-centre. double-blind, placebo controlled three part study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and repeat doses of nebulised GSK2269557 in healthy male subjects Study Listed on ClinicalStudyDataRequest.com
115119 Completed A Double-Blind (sponsor unblind), Placebo Controlled, Randomised, Parallel Group Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of GSK2269557 Administered as a Dry Powder to COPD Patients and Assessment of Dose Response using Sputum Biomarkers Study Listed on ClinicalStudyDataRequest.com
115-120 Completed A Comparative Trial of a Combination of Atovaquone and Proguanil versus Chloroquine or Fansidar in the Treatment of Acute P. falciparum Malaria in Adults in Zambia
115-122 Completed Comparative Clinical Trial of a Combination of Atovaquone and Proguanil with Mefloquine in the Treatment of Acute P. falciparum Malaria in Adults in Thailand
115123 Completed A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects with Generalized Myasthenia Gravis (MG)
115-123 Completed Uncontrolled Clinical Trial of a Combination of Atovaquone and Proguanil in the Treatment of Acute P. falciparum Malaria in Children in Thailand
115-127 Completed Comparative Clinical Trial of a Combination of Atovaquone and Proguanil Versus a Combination of Quinine and Tetracycline in the Treatment of Acute P. falciparum Malaria in Adults in Brazil
115-130 Completed Comparative clinical trial of a combination of atovaquone and proguanil versus halofantrine in the treatment of acute P. falciparum malaria in non-immune adults in Europe
115-131 Completed Comparative clinical trial of a combination of atovaquone and proguanil versus halofantrine in the treatment of acute P. falciparum malaria in children in Kenya
115-132-V Completed A Study to Compare the Bioavailability of Atovaquone and Proguanil from Combination Tablets and from Atovaquone Tablets and Proguanil Tablets given Concomitantly
115-133 Completed Report of a Randomised Study to Evaluate a Potential Pharmacokinetic Interaction between Proguanil and Atovaquone in Healthy Adult Volunteers
115134 Completed A randomised, double-blind, placebo-controlled, cross-over study to evaluate the effect of treatment with repeat dose GSK2190915 as an add-on to current therapy on the percentage of neutrophils in induced sputum in asthmatic patients with elevated sputum neutrophils Study Listed on ClinicalStudyDataRequest.com
115-134 Completed Comparative clinical trial of a combination of atovaquone and proguanil versus amodiaquine in the treatment of acute P. falciparum malaria in adults in Gabon
115-135 Completed Final Study Report for Protocol 115-135: Comparative Clinical Trial of a Combination of Atovaquone and Proguanil versus Chloroquine in the Treatment of Acute P. falciparum Malaria in Adults and Children in the Philippines

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.